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Gram-Negative	Bacteria	and	Sepsis
Christine	Ridge,	R.N,	B.S.N
Introduction
Otterbein	University,	Westerville,	Ohio
• Sepsis	 is	defined	 as	 the	manifestation	 of	 two	or	more	 signs	
of	 systemic	 inflammatory	 response	 syndrome	 (SIRS)	criteria	
and	a	documented	 suspected	 infection	 (Palleschi,	 Sirianni,	
O'Connor,	 Dunn,	 &	Hasenau,	 2014,	 p.	23). 	 	
• SIRS	is	 a	group	 of	 symptoms/respon ses	 within	 the	patient	
that	are	activated	 by	bacteria	 (gram-positive	 and	gram-
negative),	 viruses,	 fungus,	 and	non-infectious	 agents	 like	
trauma	 and	burns.	 	SIRS	can	be	defined	 as	having	 two	 or	
more	of	 the	 following	 symptoms:	 Body	 temperature	 higher	
than	100.4	degrees	 Fahrenheit	 or	 lower	 than	 96.8	degrees	
Fahrenheit,	 heart	 rater	greater	 than	90/min,	
hyperventilation	 evidenced	 by	 respiratory	 rate	 greater	 than	
20/min	 or	PaCO2	 lower	 than	32	mm	Hg,	and	white	 blood	 cell	
count	 greater	 than	 12,000	 cells/	 uL or	 lower	 than	 4,000/	 uL
(Chong	 et	al. ,	2015,	 p.	112).
• In	addition	 to	meeting	 two	or	more	 symptoms	 of	SIRS,	 the	
identification	 of	a	causative	 or	 suspected	
microorganism/infection	 must	be	 identified	 (Sagy,	Al-qaqaa,	
&	Kim,	 2013,	 p.	260).	 	
Signs	and	Symptoms
Underlying	Pathophysiology	
• Gram-negative	 bacteria	 contain	 an	assortment	 of	mechanisms	 that	enable	 them	to	evade	 the	
hosts	 immune	 system	 and	become	resistant	 to	a	multiple	 antibiotics	 resulting	 in	 sepsis	 in	 the	
host.	 	
• Mechanism’s	 of	evasion	 include:	 the	production	 of	extended-Beta-lactamases	 (ESBL)	(this	
enzyme	 inactivates	 a	variety	 of	antibiotics	 [i.e.penicillin,	 cephalasporins,	 and	aztreonam],	
modification	 of	drug	 targets,	 and	 production	 of	 the	endotoxin	 Lipolysaccharide (LPS)	which	
causes	 the	 release	 of	pro-inflammatory	 mediators	 like	macrophages,	 cytokines,	 leukotrienes,	 and	
chemokines	 in	 the	patient	 resulting	 in	 local	 inflammation	 vasodilation,	 increased	 capillary	
permeability,	 clot	 formation and	 the	pathogenesis	 of	 sepsis	 (Chong	 et	al. ,	2015,	 p.	114).		
• In	a	 septic	 host	 this	 response	 is	 exaggerated	 and	adversely	 effects	 the	patient.	 The	 increased	
capillary	 permeability	 results	 in	 fluid	 shift	 from	the	 intravascular	 space	 to	 the	 interstitial	 tissues	
resulting	 in	 hypotension inadequate	 tissue	 perfusion,	 lactic	acidosis,	 systemic	 vasodilation,	 and	
cellular	 hypoxia	 (Dunkley	&	McLeod,	 2015).
• The	hosts	 innate	 immune	 system	 continues	 its	 pro-inflammatory	 response	 by	activating	 the	
complement	 system	 and	clotting	 cascade.	
• In	summation,	 the	pathogenesis	 of	 sepsis	 can	be	broken	 down	 into	 three	mechanisms.	 	
Mechanism	 1:	The	 pro-inflammatory	 response,	 mechanism	 2:	Failure	 of	 the	compensatory	 anti-
inflammatory	 response	 (CARS),	 and	mechanism	 3:	immunoparalysis which	 is	 the	 result	 of	
inflammation	 overpowering	 the	patient’s	 immune	 system	 paralyzing	 it,	 leading	 to	 the	 failure	 of	
the	 immune	 system	 to	neutralize	 pathogens	 (Sagy et	al. ,	2013,	 p.	261).
Today’s	 medical	 world	 encompasses	 an	environment	 in	 which	
gram-negative	 bacteria	 that	 once	were	defeated	 with	 common	
antibiotics,	 have	 now	become	 resistant.	 Gram-negative	
bacteria	 like	Klebsiella pneumoniae,	 Pseudomonas	 aeruginosa,	
Enterobacter,	 and	Acinetobacter	 are	pathogens	 that	are	an	
emerging	 threat	 causing	 sepsis	 due	 to	multidrug-resist ance	
(Pop-Vicas &	Opal,	 2014,	 p.189).	 		The	multidrug-resistance	
mechanisms	 of	gram-negative	 bacteria	 coupled	 with	 a	patient	
population	 commonly	 seen	 in	hospital	 settings,	 that	 consist	 of	
immunocompromised	 adults	 due	 to	advancing	 age,	
comorbidities	 (e.g.	AIDS,	history	 of	 transplants,	 diabetes,	 and	
chemotherapy),	 and	 immunotherapies,	 create	an	environment	
for	advanced	 infection	 or	 sepsis	 to	 take	place.	 	
Complications	 of	multidrug-resistant	 gram-negative	 bacteria	
can	cause	 infection	 and	ultimately	 sepsis	 in	 the	host.	Sepsis	 is	
also	 a	very	deadly	 condition	 with	 high	morbidity	 and	mortality	
rates.	 	Chong	 et	al. ,	 (2015),	estimated	 that	 there	 are	
approximately	 258,000	 people	 killed	 in	 the	US	annually	 due	 to	
sepsis	 with	 a	mortality	 rate	between	 18%	and	 40%	 for	 those	
that	contract	 the	 disease	 (p.	111).	 	
The	 topic	 of	gram-negative	 bacteria	 and	sepsis	 was	 chosen	 due	
to	 the	medical	 challenge	 presented	 to	healthcare	 providers	 and	
the	high	 mortality	 rates	 associated	 with	 gram-negative	
bacteria.	 	Traditional	 management	 and	 treatment	 of	sepsis	
resulting	 from	 gram-negative	 bacteria	 is	no	 longer	 effective	and	
healthcare	 providers	 are	having	 to	update	 and	modify	 current	
sepsis	 protocols	 to	 fight	 the	 infection.
Significance	of	Pathophysiology
• Understanding	 the	 pathophysiology	 of	gram-negative	 bacteria	 and	sepsis	 is	 imperative	 to	
successfully	 treat	 and	 reduce	 the	 risk	of	mortality	 of	 the	patient.	
• Understanding	 the	bodies	 response	 to	severe	 infection	 causing	 sepsis	 has	 led	 to	 the	
development	 of	 sepsis	 treatment	 bundles.	 	 Lu	et	al. ,	2015,	 defines	 sepsis	 treatment	 bundles	
as	a	group	of	evidence-based	 interventions	 that	provide	 greater	 benefit	 for	 the	patient	 when	
administered	 together	 as	compared	 with	 any	single	 intervention	 (p.	1045.)	 	
• The	 interventions	 applied	 in	 the	sepsis	 treatment	 bundles	 are	directed	 towards	 the	
pathophysiology	 of	 sepsis	 and	 the	 course	 the	 pathogen	 takes	 in	 the	patient’s	 body	 (i.e
reversing	 hypotension,	 glucose	 control	 to	minimize	 optimal	 environment	 for	pathogen,	 and	
broad	 spectrum	 antibiotics	 due	 to	pending	 blood	 culture	 results).
Implications	for	Nursing
• Sepsis	 treatment	 bundles	 require	 that	
blood	 cultures	 are	drawn	 to	determine	
the	source	 of	 infection.	 	However,	
results	 from	the	cultures	 take	up	 to	
three	 days	 to	grow	 and	 result. 	 	A	 nurse	
practitioner’s	 knowledge	 of	 the	high	
probability	 of	a	gram-negative	 infection	
and	 the	 prevalence	 of	multi-drug	
resistant	 bacteria	 should	 guide	 her	 to	
the	proper	 antibiotic	 treatment	 (Pop-
Vicas &	Opal,	 2014,	 p.	192).	
• With	 the	prevalence	 of	gram-negative	
bacteria	 related	 sepsis	 and	 multi-drug	
resistance,	 combination	 broad-
spectrum	 antibiotic	 therapy	 proves	 to	
be	beneficial. 	 	
• Once	blood	 culture	 results	 are	obtained	
the	combination	 antibiotic	 treatment	
can	be	de-escalated	 or	 limited	 to	 those	
that	 the	bacteria	 is	 responsive	 to	 (Pop-
Vicas &	Opal,	 2014,	 p.	192).
Conclusion
• The	Nurse	 Practitioners	 understanding	 of	
the	pathophysiology	 of	 sepsis	 and	 gram-
negative	 bacteria	 is	 imperative	 to	
successfully	 treat	 the	patient	 and	 reduce	
mortality.	 	
• With	 this	 high	 level	 of	knowledge	 and	
understanding,	 efforts	 to	deliver	
combination	 therapy	antibiotics	 and	
resuscitation	 earlier	 has	 led	 to	new	
approaches	 to	sepsis	 that	have	shown	
success	 (Wunderink &	Walley,	 2014,	p.	28). 		 	
• A	practitioner’s	 knowledge	 of	 the	course	
of	 sepsis	 and	gram-negative	 bacteria	 drug	
resistance	 allows	 for	 rapid	 assessment	 and	
can	 lead	 to	practice	 changes	 to	antibiotic	
therapy	 and	sepsis	 bundles.	
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